You are here: Home » Healthcare » Technologies


We dedicate our internal R&D to developing novel technologies that solve industry challenges, and form strategic partnerships with the healthcare sector to help innovate and commercialize technologies and products.

iCRT (inorganic Controlled Release Technology)

  • Tailored release allows you to control the rate of active delivery with a high level of precision
  • Our materials research forms the basis of our drug delivery work and product line
  • iCRT (inorganic Controlled Release Technology) has been developed by our experts for delivery of key actives.


Are you working with sensitive compounds and need a technology to protect them?

Organic molecules can impart beneficial functionality to products, but are often sensitive to “harsh” environments, including:

  • High temperatures
  • Extreme pH
  • Chemical attack
  • Strong ionic concentrations
  • Exposure to organic solvents.

Many encapsulation technologies are also organic (polymer) based, making them of little use for applications where shielding or protection is desired – either during processing/manufacturing, or in the end application/in use.

Lucideon’s encapsulation and controlled release technology platforms (iCRT) use inorganic materials, such as silicate- and phosphate- based glasses or ceramics. Naturally, these materials are much more resistant to extreme environments.


  • Enhanced biocompatibility and bioactivity
  • Multi-substituted hydroxyapatite for bone/tooth replacement, repair and drug delivery applications.

Flash Sintering

  • A world first
  • A low-energy ceramic processing technology, based on the application of an electric field to the ceramic body during sintering.

Contact Us

Get in touch

  • Advanced Materials & Processes Newsletter

    Latest Issue

    View PDF